BOULDER — Edgewise Therapeutics Inc. has begun recruiting its first-ever clinical trial for its flagship muscular dystrophy treatment. The Boulder […]
Source: BizWest
BOULDER — Edgewise Therapeutics Inc. (Nasdaq: EWTX), a clinical-stage biopharmaceutical company developing drugs to treat muscular dystrophy, has observed positive…
BROOMFIELD — Flagship Biosciences Inc., a Broomfield-based spatial-biology company, has formed a strategic partnership with Genomenon Inc., based in Ann…